Biorestorative Therapies Stock Short Ratio
| BRTX Stock | USD 1.97 0.06 2.96% |
BioRestorative Therapies fundamentals help investors to digest information that contributes to BioRestorative Therapies' financial success or failures. It also enables traders to predict the movement of BioRestorative Stock. The fundamental analysis module provides a way to measure BioRestorative Therapies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioRestorative Therapies stock.
BioRestorative | Short Ratio |
BioRestorative Therapies Company Short Ratio Analysis
BioRestorative Therapies' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current BioRestorative Therapies Short Ratio | 1.07 X |
Most of BioRestorative Therapies' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioRestorative Therapies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
BioRestorative Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for BioRestorative Therapies is extremely important. It helps to project a fair market value of BioRestorative Stock properly, considering its historical fundamentals such as Short Ratio. Since BioRestorative Therapies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BioRestorative Therapies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BioRestorative Therapies' interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
BioRestorative Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, BioRestorative Therapies has a Short Ratio of 1.07 times. This is 72.56% lower than that of the Biotechnology sector and 85.56% lower than that of the Health Care industry. The short ratio for all United States stocks is 73.25% higher than that of the company.
BioRestorative Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioRestorative Therapies' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioRestorative Therapies could also be used in its relative valuation, which is a method of valuing BioRestorative Therapies by comparing valuation metrics of similar companies.BioRestorative Therapies is currently under evaluation in short ratio category among its peers.
BioRestorative Therapies Current Valuation Drivers
We derive many important indicators used in calculating different scores of BioRestorative Therapies from analyzing BioRestorative Therapies' financial statements. These drivers represent accounts that assess BioRestorative Therapies' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BioRestorative Therapies' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 10.9M | 5.2M | 9.9M | 7.3M | 6.6M | 5.4M | |
| Enterprise Value | 12.6M | (15.2M) | 8.6M | 6.6M | 7.6M | 4.5M |
BioRestorative Therapies Institutional Holders
Institutional Holdings refers to the ownership stake in BioRestorative Therapies that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of BioRestorative Therapies' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing BioRestorative Therapies' value.| Shares | Tower Research Capital Llc | 2024-09-30 | 2.2 K | Ubs Group Ag | 2024-09-30 | 693 | Bank Of America Corp | 2024-09-30 | 42.0 | Td Waterhouse Canada Inc | 2024-09-30 | 2.0 | Jjj Advisors Inc | 2024-06-30 | 1.0 | Wells Fargo & Co | 2024-09-30 | 0.0 | Sabby Management Llc | 2024-06-30 | 0.0 | Two Sigma Investments Llc | 2024-06-30 | 0.0 | Geode Capital Management, Llc | 2024-09-30 | 55.7 K | Stonex Group Inc | 2024-09-30 | 50.1 K | Wealth Alliance, Llc | 2024-09-30 | 40 K |
BioRestorative Fundamentals
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.53 | ||||
| Operating Margin | (9.79) % | ||||
| Current Valuation | 600.77 K | ||||
| Shares Outstanding | 6.92 M | ||||
| Shares Owned By Insiders | 26.61 % | ||||
| Shares Owned By Institutions | 13.74 % | ||||
| Number Of Shares Shorted | 109.01 K | ||||
| Price To Earning | (1.79) X | ||||
| Price To Book | 1.37 X | ||||
| Price To Sales | 36.16 X | ||||
| Revenue | 145.8 K | ||||
| Gross Profit | 352.27 K | ||||
| EBITDA | (15.06 M) | ||||
| Net Income | (10.42 M) | ||||
| Cash And Equivalents | 17.93 M | ||||
| Cash Per Share | 4.92 X | ||||
| Total Debt | 162.32 K | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 29.47 X | ||||
| Book Value Per Share | 1.44 X | ||||
| Cash Flow From Operations | (6.43 M) | ||||
| Short Ratio | 1.07 X | ||||
| Earnings Per Share | (2.38) X | ||||
| Target Price | 13.0 | ||||
| Number Of Employees | 11 | ||||
| Beta | 62.82 | ||||
| Market Capitalization | 13.63 M | ||||
| Total Asset | 12.61 M | ||||
| Retained Earnings | (146.7 M) | ||||
| Working Capital | 8.78 M | ||||
| Current Asset | 289.28 K | ||||
| Current Liabilities | 5.61 M | ||||
| Net Asset | 12.61 M |
About BioRestorative Therapies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioRestorative Therapies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioRestorative Therapies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioRestorative Therapies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioRestorative Stock Analysis
When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.